semaglutide canada approves generic from Dr. Reddy's, a G7 first enabled by Novo Nordisk's lapsed CAD$250 patent Wegovy: Canada approves first generic

BPC-157 has a shorter half-life (approximately 4 hours) and is predominantly used in gastrointestinal and tendon research

Within a short span, GLP-1 drugs moved from specialist therapy to a global healthcare obsession, redefining obesity treatment and attracting massive investor and consumer attention

They can cause a dangerous condition called euglycemic DKA where blood sugar appears normal but the body is in ketoacidosis

Return cap to bottle and tighten

The Rebound: What the Best Data Now Shows The question Ive had about these drugs from the beginning is whether the weight loss persists after people stop taking them